CydeWeys

If you've ever tried to parse WHOIS programmatically, you'd realize that it being an unstructured blob of text is actually quite unconducive to it being useful. Having every endpoint return a standardized JSON payload specified in an RFC is much better.

If you're trying to debug why a website's setup isn't working, the first step is to see if what the registry thinks the nameservers should be matches what the nameservers in DNS actually are. These can fall out of sync if e.g. the registry's connection to its DNS provider is experiencing issues. This does actually happen from time to time.

How do you determine the value of a domain name? Also there's nothing particularly valuable for most short domain name strings except on .com. It's generic words that tend to be valuable, not a short random string.

GDPR is what changed this. Before that, registrars had little incentive to hide it for free when they could instead charge you for the service. It was not trivial that Google Domains (rip) came with free privacy proxy right from the beginning.

> But if you look at many cities you'll see that population has not grown significantly.

You've got cause and effect backwards here. The population hasn't grown because the housing hasn't been built for them. The city population would have grown if more housing were available, but instead what happened is that the limited supply drive rents up and kept some people out.

Separately, there's also too few hotels in the city to accommodate tourists, so some housing was converted to that more profitable use. It all can be traced back to not building enough to satisfy increasing demand.

Ahhh OK so it's essentially the null or identity value, saying "you don't need this component for an exact representation". That makes sense, thanks.

It's not wasted effort at all, as this app comes installed by default for over a billion users. Only a tiny fraction will ever install another calculator app, so the default one better work entirely correctly. When you have that many users it's hard to waste effort on making the product better.

> Obviously we'll want a symbolic representation for the real number 1

Sorry, why is this obvious? A basic int type can store the value of 1, let alone the more complicated Rational (BigNum/BigNum) type they have. I can absolutely see why you want symbolic representations for pi, e, i, trig functions, etc., but why one?!

> Having everyone together in one place at one time is what makes the Olympics special. Special for the athletes, live spectators & host city alike.

A good idea in theory, but in practice the cost of hosting the entire Olympics in a single city has become so cost-prohibitive infrastructure-wise that very few are even willing to do it anymore. We already see that with the winning LA bid for the next summer Olympics, where they're not building anything new to host it.

It's not an exception at all. People get promoted all the time. Most people I work with have been promoted at least once since joining the company, some multiple times like I have.

They're talking about referrals, not reference checks. Getting good referrals is hugely important, especially at smaller companies that don't the capacity to do a rigorous hiring process.

"Going above and beyond" at a big company, if done in a smart strategic way, is the best way to get promoted, and getting promoted results in significantly higher pay. I've gotten promoted twice at my current employer over the years, which has roughly doubled my total compensation, and none of that would have happened had I just did my previous level's responsibilities and nothing beyond.

People are routinely killed by falling bullets. It turns out that the vast majority of idiots firing blindly into the air don't know or care to shoot only straight up, and it would be the same problem for whichever idiots were trying to shoot down drones.

There aren't workers doing those jobs in the US anymore. 100% of those close-to-the-actual-manufacturing jobs were outsourced. The remaining people in the US aren't doing the same jobs; they're doing HQ stuff.

> Again, offshoring normally implies that there are workers still in an "onshore" office.

Not workers doing the same jobs though. Look at how manufacturing was offshored over the past several decades -- for many companies, entire job trees within the US were eliminated. HQ is still in the US, but anything remotely having to do with manufacturing isn't. You have to go really high up the chain in those offshored manufacturing jobs before you see anyone actually interacting with an employee in the US.

> If after the price increase there are 10% (50) parking spots open, that means at least a 100 people went elsewhere (20%).

Your math ain't mathing.

To be clear, version a is referring to literal (non-metaphorical) crutches, and is not the version being used here because GLP-1 agonists are not literal crutches. Version b is the only possible use of the word being used in this conversation, and is always pejorative. "Oh, you broke your foot, you're getting around on a crutch" = Always version A, literal, non-pejorative. "Oh, you're obese, you're using medicine as a crutch to cure it" = Always version B, metaphorical, pejorative. There's no confusion.

Exactly! For many drugs it's essentially a funny accident of history that they were originally discovered while attempting to cure something completely unrelated to what is now their primary usage.

There's not that much free space available. It's a maximum of 10%. Almost everyone who was ever going to be able to go here is able to do so, they're just paying more for the privilege and they aren't wasting as much time driving around creating traffic trying to find parking.

Unless you're gonna make it fully automated, it's not gonna work here as it can't be within kilometers of the landing site during landing in case there's a catastrophic failure.

People don't realize that Ozempic is already a third generation GLP drug, Mounjaro is a 4th, and the try generation drugs are already in wide scale clinical trials.

We do in fact know a lot about how these drugs affect people by now, and as you point out, we have well over a decade of data on them.

Amazingly enough, the drugs do address the root of the problem. Snacking / junk food is less appealing on them.

> Cities and councils should not be making decisions based on how to raise revenue.

... although if they were, the price of parking would be way higher. The optimal price for parking is a time-and-day-dependent price set high enough that around 10% of spots everywhere in the city are free at any given time, so that people who need parking can generally find it conveniently nearby to where they're going.

So I live in NYC, and constant honking and worrying about being run over by cars when I'm trying to cross the street contribute way more to my stress than the state of the subway in NYC. Driving, or being around vehicles driving, is incredibly stressful.

Also, I was in Paris last year and I found your subway system more pleasant than ours. Methinks you doth complain too much.

> This is a diabetes drug, remember.

No, Wegovy and Zepbound are not diabetes drugs. They are weight loss drugs.

> ... but problems with controlling themselves around food.

Problems that Wegovy and Zepbound solve for most people taking them, when no other solution worked for those people.

> There are hugely beneficial approaches that rely on CBT,

CBT is much more expensive, time-intensive, and less effective for weight loss than GLP-1 drugs. It also scales incredibly poorly, as you need a huge number of therapists. There are roughly a hundred million obese Americans. We can make enough drugs to treat all them, but can we make and pay for several million therapists to perform CBT on all of them, all for less efficacy than the GLP-1 agonists? Fat chance.

> maybe some therapy for addiction (of all kinds) and a shift in focus toward health is a better idea than being on a drug for the rest of your life.

It doesn't work for nearly as many people as GLP-1 agonists do. There are many different treatment methods that have been tested and evaluated, and being told to diet and exercise through therapy barely works at all. GLP-1 by contrast works very well.

> At some point, we may find that these drugs cause long-term health problems of their own, too.

Almost sounds like wishful thinking on your part -- you might want to stop and consider why you're so invested in these drugs having long-term side effects.

The marginal cost to produce the few milligrams of the drug that goes into the pens is much much less than $2.83; it's on the order of cents. Plus, scaling up manufacturing of the drug is easier than scaling up manufacturing of the auto-injectors (which have a decent number of parts in them). The auto-injectors really are the bottleneck, and manufacturing of them so far has not been able to be ramped up quickly enough.

Realistically this treatment is just not available to most people (for the simple reason that there are way too few non-car-dependent cities in the US, and the ones that there are are super expensive). But GLP1 agonists are available to most people.

There are also doctors that are prescribing vials of semaglutide and commodity needles, and training patients to properly dose up and administer the drug via a standard needle. There's more to it than the auto-injector pens, but not that much more to it. And it does bring costs down, which is important to some. Alternatively, you can just go to the doctor's office weekly and have a nurse there do a traditional injection for you (doesn't help as much with costs, but does bypass the auto-injector shortage).

Everyone who's obese has been prescribed exercise and a better diet. It's the quintessential doctor cliche, and yet it indeed hasn't worked for them. GLP1 agonists do.